LAUSR

Introduction Phototherapy is a standard treatment for dermatologic diseases such as psoriasis in patients with moderate to severe disease. Compared with alternative systemic therapies such as biologics, it has fewer side effects and costs, with comparable efficacy. However, it often requires in-office treatments two to three times a week, resulting in a substantial patient burden, such as the inability to attend during office hours, lengthy travel times to the medical office, and a significant financial burden resulting from the high cost of treatment co-pays, that in the case of most commercial insurers, is equal to that of a physician specialist visit. Home phototherapy can reduce many barriers to care. This study determined disease, quality-of-life, and treatment satisfaction outcomes from a home phototherapy program at our academic center involving all stakeholders’ alliance (insurance carrier, instrument manufacturer, health providers, and hospital pharmacy).